(Q81703452)
Statements
Early initiation of lipid-lowering therapy for acute coronary syndromes improves compliance with guideline recommendations: observations from the Orbofiban in Patients with Unstable Coronary Syndromes (OPUS-TIMI 16) trial (English)
Sabina A Murphy
Charles S Smith
Christopher P Cannon
Carolyn H McCabe
Jane Bentley
Eugene Braunwald